|

A Registry Study of Biomarkers in Heart Valve Disease

RECRUITINGSponsored by Beijing Institute of Heart, Lung and Blood Vessel Diseases
Actively Recruiting
SponsorBeijing Institute of Heart, Lung and Blood Vessel Diseases
Started2016-01-01
Est. completion2030-01-01
Eligibility
Age18 Years – 100 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06223906

Summary

Valvular Heart Disease, impacting 2.5% of the population, is predominantly observed in the elderly and is on the rise. The primary conditions within this category are Aortic Stenosis and Mitral Regurgitation. These conditions are linked to considerable morbidity and mortality, presenting a formidable challenge in optimizing treatment strategies. Pathophysiology of Valvular Heart Disease remains poorly known. The aim of the present study is to identify biomarkers involved in this disease using multi-omics approaches

Eligibility

Age: 18 Years – 100 YearsHealthy volunteers accepted
Inclusion Criteria:

* Patients clinically diagnosed with heart valve disease in Beijing Anzhen Hospital

Exclusion Criteria:

* Age \< 18 years
* Failure to obtain medical records and ultrasound data
* Refuse follow-up

Conditions2

Cardiovascular DiseasesHeart Disease

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.